Return to homepagePandemic Pact

Identification of Biomarkers that Predict Severity of Infection in COVID-19 Patients. Dr. David Kelvin Dalhousie University RNS Funding Contribution: $600,000 Total Project Value: $1,900,000 Funding Partners: Dalhousie Medical Research Foundation (DMRF), Canadian Institutes of Health Research (CIHR) Key Words: COVID-19, biomarkers, patients, health, infection, illness, coronavirus https://researchns.ca/2020/03/18/coronavirus-research/ https://researchns.ca/episode1/ https://www.dal.ca/news/2020/04/01/covid-19-researchers-profile-dr-david-kelvin.html

Grant search

Key facts

  • Disease

    COVID-19

  • start year

    2021

  • Funder

    Research Nova Scotia

  • Principal Investigator

    Dr. David Kelvin

  • Research Location

    N/A

  • Lead Research Institution

    N/A

  • Research Priority Alignment

    N/A

  • Research Category

    Clinical characterisation and management

  • Research Subcategory

    Prognostic factors for disease severity

  • Special Interest Tags

    N/A

  • Study Type

    Clinical

  • Clinical Trial Details

    Unspecified

  • Broad Policy Alignment

    Pending

  • Age Group

    Unspecified

  • Vulnerable Population

    Unspecified

  • Occupations of Interest

    Unspecified

Abstract

COVID-19, biomarkers, patients, health, infection, illness, coronavirus